Science Explorer Back to mapMap
Discussion
Topic · Hepatology

Hepatitis Viruses Studies and Epidemiology

Hepatitis Viruses Studies and Epidemiology is a research topic within Hepatology. Science Explorer counts 21k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the epidemiology, transmission, and clinical aspects of Hepatitis E virus infection. It covers topics such as zoonotic transmission, chronic infection in organ transplant recipients, vaccine efficacy, genetic diversity, and the impact of Hepatitis E on pregnancy. Additionally, it explores the use of ribavirin therapy and the potential risks associated with food safety.

  • Hepatitis E Virus
  • Zoonotic Transmission
  • Chronic Infection
  • Vaccine
  • Genetic Diversity
  • Organ Transplant Recipients
  • Food Safety
  • Epidemiology
  • Pregnancy
  • Ribavirin Therapy
Research works
21k
fractional, since 1950
In the world top 10%
2.1k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-7%
the tick is no change
Largest producer
United States
25% of the 10 largest, 2022-now
Hepatitis Viruses Studies and Epidemiology

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Hepatitis Viruses Studies and Epidemiology research?

By volume, the United States and China publish the most (459 and 443 works in 2022-now).

By volume, 2022-now

  1. 1 United States 459 works
  2. 2 China 443 works
  3. 3 India 249 works
  4. 4 Germany 130 works
  5. 5 United Kingdom 104 works
  6. 6 France 101 works
  7. 7 Türkiye 93 works
  8. 8 Spain 93 works
  9. 9 Japan 90 works
  10. 10 Italy 88 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 24.8%China: 24.0%India: 13.4%Germany: 7.0%6 others listed: 30.8%25%largest
United States459 · 24.8%China443 · 24.0%India249 · 13.4%Germany130 · 7.0%6 others listed569 · 30.8%

Shares of the rows listed above, not of the whole node.

Which institutions lead Hepatitis Viruses Studies and Epidemiology research?

By volume in 2022-now, University of North Carolina at Chapel Hill publishes the most Hepatitis Viruses Studies and Epidemiology research, followed by United States Department of Health and Human Services and Peking University.

Who are the leading researchers in Hepatitis Viruses Studies and Epidemiology?

The most-cited researchers publishing on Hepatitis Viruses Studies and Epidemiology include Christopher J L Murray, Theo Vos and Ali H. Mokdad.

  1. 1 Christopher J L Murray United States 583k citations
  2. 2 Theo Vos United States 439k citations
  3. 3 Ali H. Mokdad United States 429k citations
  4. 4 Zulfiqar Ahmed Bhutta Pakistan 371k citations
  5. 5 Jun Wang China 340k citations
  6. 6 Matthias Egger Switzerland 326k citations
  7. 7 Stephen S Lim United States 294k citations
  8. 8 Reza Malekzadeh Iran 278k citations
  9. 9 Yousef Saleh Khader Jordan 274k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Hepatitis Viruses Studies and Epidemiology?

The most cited paper in Hepatitis Viruses Studies and Epidemiology is "Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial" (Michael Peter Manns, John G. McHutchison, Stuart C. Gordon et al., 2001), with 6,056 citations. Next come "Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C" (3,509) and "Expanding consensus in portal hypertension" (3,103).

Most cited papers
#PaperReleasedCitations
1 Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Michael Peter Manns, John G. McHutchison, Stuart C. Gordon et al. · The Lancet Sep 2001 6,056
2 Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C John G. McHutchison, Stuart C. Gordon, Eugene R. Schiff et al. · New England Journal of Medicine Open access 19 Nov 1998 3,509
3 Expanding consensus in portal hypertension Roberto de Franchis · Journal of Hepatology Open access 5 Jun 2015 3,103
4 Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C Stephanos J. Hadziyannis, Hoel Sette, Timothy R. Morgan et al. · Annals of Internal Medicine 2 Mar 2004 2,842
5 Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 Aparna Schweitzer, Johannes Horn, Rafael Mikolajczyk et al. · The Lancet Review 28 Jul 2015 2,802
All 100 most cited papers, with filters and sorting

Where is Hepatitis Viruses Studies and Epidemiology research done?

The largest centres of Hepatitis Viruses Studies and Epidemiology research in 2022-now are Beijing (China), London (United Kingdom), Paris (France) and New Delhi (India). Among places with at least 20 works in it, it is an unusually large share of all research in Chapel Hill.

Largest cities, 2022-now

  1. 1 BeijingChina 89 works
  2. 2 LondonUnited Kingdom 43 works
  3. 3 ParisFrance 42 works
  4. 4 New DelhiIndia 37 works
  5. 5 MoscowRussia 34 works
  6. 6 MadridSpain 32 works
  7. 7 ShanghaiChina 32 works
  8. 8 GuangzhouChina 31 works
  9. 9 TokyoJapan 26 works
  10. 10 SeoulSouth Korea 26 works

Where it is the local speciality

  1. Chapel HillUS · 24.4 works4.3×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Hepatitis Viruses Studies and Epidemiology than the world average.

See Hepatitis Viruses Studies and Epidemiology on the map

Where is the best place to study Hepatitis Viruses Studies and Epidemiology?

Among universities, judged by research, University of Hong Kong, Peking University and University of North Carolina at Chapel Hill score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 14.91%fractional works in this field (log) →share of work in the world top 10% →University of Hong K…Peking UniversityMedizinische Hochsch…University of North …
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1University of Hong KongChina 69.526.3%4.1×10 +57.7%
2Peking UniversityChina 61.923.1%3.2×18 +16.4%
3University of North Carolina at Chapel HillUnited States 60.64.4%5.1×25 +23.7%
4Medizinische Hochschule HannoverGermany 47.419.6%12.9×9 +38.5%
5All India Institute of Medical SciencesIndia 45.06.8%4.9×15 +49.6%
6The Ohio State UniversityUnited States 42.215.3%2.8×9 +7.4%
7Harvard UniversityUnited States 40.812.5%1.5×13 +2.4%
8Zhejiang UniversityChina 39.612.3%1.8×13 +25.0%
9Fudan UniversityChina 38.214.5%2.6×12 +11.1%
10Capital Medical UniversityChina 37.414.3%4.2×12 +4.0%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Hepatitis Viruses Studies and Epidemiology, country by country

Is Hepatitis Viruses Studies and Epidemiology research growing?

Output in 2022-2025 was 7% lower than in 2018-2021, peaking in 2018.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Hepatitis Viruses Studies and Epidemiology as a percentage of every work published that year, 0.013% in 2024.

still counting0.020%0.040%Hepatitis Viruses Studies and Epidemiology0.012% in 202519801990200020102020

Fractional works of Hepatitis Viruses Studies and Epidemiology over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Hepatitis Viruses Studies and Epidemiology10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Hepatitis Viruses Studies and Epidemiology. Posts are plain text and can be reported.